Related Experiment Video
Updated: May 23, 2026

A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis
Published on: March 14, 2025
[Bullous dermatosis--treatment up-to-date]
Etsuko Komiyama1, Shigaku Ikeda
1Department of Dermatology and Allergology, Juntendo University Graduate School of Medicine.
Abstract:
Blistering dermatosis are generally known to be constructed of two groups, autoimmune blistering dermatosis and genodermatosis. Autoantibodies are determined in autoimmune blistering dermatosis including pemhigus and bullous pemphigoid. We used to treat them with systemic corticosteroids and various immunosuppressants, with attention to side effects. Apheresis or intravenous immunoglobulin (IVIG) therapy is recommended as a combination therapy with systemic corticosteroids and various immunosuppressants. Some of responsible genes have been elucidated in blistering genodermatosis such as epidermolysis bullosa. Although no specific treatment is available, cell-based therapies using bone marrow cells and fibroblasts improve the quality of life in these patients. In this review, we present an overview of the treatment of blistering dermatosis.
Related Concept Videos
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Acne Infection
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
